OnDemand

Increasingly, manufacturers are establishing policies that define 340B pricing eligibility for covered entities who purchase through a contract pharmacy. In order to effectively control revenue leakage, those policies should follow through to downstream chargeback and rebate validation and adjudication. Access the recording to hear more about system and process considerations that allow for more effective chargeback adjudication and targeted 340B duplication identification in Managed Care and Medicaid.

Andrew Brownlee
Director at Berkeley Research Group LLC

Chad Garber
Executive Director, Solutions